Evidence map›Paper›PMID 32955012›Full record

ArticleJournal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2021

Impact of sleep-disordered breathing on glucose metabolism among individuals with a family history of diabetes: the Nagahama study.

Takuma Minami, Takeshi Matsumoto, Yasuharu Tabara, David Gozal, Dale Smith, Kimihiko Murase, Kiminobu Tanizawa, Naomi Takahashi, Yoshinari Nakatsuka, Satoshi Hamada and 17 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 51% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

27 authors at 6 institutions in 2 countries.

Takuma MinamiDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takeshi MatsumotoDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yasuharu TabaraCenter for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
David GozalDepartment of Child Health and Child Health Research Institute, University of Missouri School of Medicine, Columbia, Missouri.
Dale SmithDepartment of Behavioral Sciences, Olivet Nazarene University, Bourbonnais, Illinois.
Kimihiko MuraseDepartment of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kiminobu TanizawaDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Naomi TakahashiDepartment of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoshinari NakatsukaDepartment of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Satoshi HamadaDepartment of Advance Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tomohiro HandaDepartment of Advance Medicine for Respiratory Failure, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Hirofumi TakeyamaDepartment of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Toru OgaDepartment of Respiratory Medicine, Kawasaki Medical School, Kurashiki, Japan.
Isuzu NakamotoNursing Science, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Tomoko WakamuraNursing Science, Human Health Sciences, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Naoko KomenamiDepartment of Food and Nutrition, Kyoto Women's University, Kyoto, Japan.
Kazuya SetohCenter for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takanobu TsutsumiCenter for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takahisa KawaguchiCenter for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Yoichiro KamataniKyoto-McGill International Collaborative School in Genomic Medicine, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Yoshimitsu TakahashiDepartment of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan.
Satoshi MoritaDepartment of Biomedical Statistics and Bioinformatics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Takeo NakayamaDepartment of Health Informatics, Kyoto University School of Public Health, Kyoto, Japan.
Toyohiro HiraiDepartment of Respiratory Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Fumihiko MatsudaCenter for Genomic Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Kazuo ChinDepartment of Respiratory Care and Sleep Control Medicine, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Nagahama Study Group
Kyoto University · JPKawasaki Medical School · JPKyoto Women's University · JPOlivet Nazarene University · USOsaka Kaisei Hospital · JPUniversity of Missouri Health System · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

STUDY

objectivesIt is well known that a family history of diabetes (FHD) is a definitive risk factor for type 2 diabetes. It has not been known whether sleep-disordered breathing (SDB) increases the prevalence of diabetes in those with an FHD.

methodsWe assessed SDB severity in 7,477 study participants by oximetry corrected by objective sleep duration determined by wrist actigraphy. Glycated hemoglobin ≥6.5% and/or current medication for diabetes indicated the presence of diabetes. In addition to the overall prevalence, the prevalence of recent-onset diabetes during the nearly 5 years before the SDB measurements were made was investigated.

resultsOf the 7,477 participants (mean age: 57.9; range: 34.2-80.7; SD: 12.1 years; 67.7% females), 1,569 had an FHD. The prevalence of diabetes in FHD participants with moderate-to-severe SDB (MS-SDB) was higher than in those without SDB (MS-SDB vs without SDB: all, 29.3% vs 3.3% [P < .001]; females, 32.6% vs 1.9% [P < .001]; males, 26.2% vs 11.7% [P = .037]). However, multivariate analysis showed that MS-SDB was significantly associated with a higher prevalence of diabetes only in FHD-positive females (odds ratio [95% confidence interval]: females, 7.43 [3.16-17.45]; males, 0.92 [0.37-2.31]). Among the FHD-positive participants, the prevalence of recent-onset diabetes was higher in those with MS-SDB than those without SDB, but only in females (MS-SDB vs without SDB: 21.4% vs 1.1%; P < 0.001).

conclusionsMS-SDB was associated with diabetes risk in females with an FHD, and future studies are needed on whether treatment of SDB in females with an FHD would prevent the onset of diabetes.

Indexed as

Diabetes Mellitus, Type 2Sleep Apnea SyndromesFemaleGlucoseHumansMaleMiddle AgedOximetryPrevalenceRisk FactorsGlucoseeffect modificationenvironmentgeneheritabilityobstructive sleep apnea

Identifiers

PMID32955012
PMCPMC7853232
OpenAlexW3087683215

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.